Strong Support
mechanistic
Analysis v3
History

In older adults with insulin resistance, levels of a specific protein called IP6K1 in the blood and muscles are lower after consuming whey protein, compared to younger adults. These lower levels are...

46
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

After eating protein or exercising, older adults don't turn down a specific enzyme the way younger people do, and this keeps a key signal from activating. As a result, muscle cells can't pull in amino acids effectively or build new proteins, even when insulin is high. This explains why older adults...

Most probable mechanism

In Simple Terms

In older adults, the body doesn't reduce a specific enzyme called IP6K1 properly after eating protein or exercising, which keeps a key signaling protein (Akt) from turning on fully. This prevents the cell from taking in amino acids efficiently and building new muscle proteins, even when insulin levels are high. Younger people reduce this enzyme after eating, which lets amino acids enter muscle cells and triggers protein synthesis, but older adults lose this ability, leading to poor nutrient use.

Causal chain
1

In older adults, muscle and plasma levels of IP6K1 remain elevated or fail to decrease after protein ingestion and resistance exercise, unlike in younger individuals where IP6K1 declines.

Verified by multiple studies
which leads to
2

Persistently high IP6K1 generates elevated levels of IP7, which binds to the PH domain of Akt and blocks its movement to the cell membrane.

Verified by multiple studies
which leads to
3

Blocked Akt translocation prevents its phosphorylation at Thr308 by PDK1, reducing downstream activation of the mTORC1 pathway.

Verified by multiple studies
which leads to
4

Impaired mTORC1 signaling reduces phosphorylation of 4E-BP1, limiting the release of eIF4E and suppressing the initiation of mRNA translation for muscle protein synthesis.

Verified by multiple studies
which leads to
5

Reduced translation initiation and impaired amino acid transporter (LAT1) upregulation decrease the rate of phenylalanine disposal, indicating diminished amino acid uptake and utilization by skeletal muscle.

Verified by multiple studies

Evidence from Studies

Supporting (1)

46

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict